Table 1.
Methods | |||||||||
Rank | TFIDF | RelFreq | Termine | Text2Onto | OntoLearn | ||||
1 | x | metabolic syndrome | review | x | low-density lipoprotein | x | patient | Mutation | |
2 | x | HDL | x | metabolic syndrome | x | cardiovascular disease | x | disease | fish oil |
3 | x | atherosclerosis | x | diabetes | x | metabolic syndrome | risk | hypercholesterolaemia | |
4 | review | x | atherosclerosis | x | risk factor | effect | Serum | ||
5 | x | LDL | x | HDL | x | cardiovascular risk | study | progression of atherosclerosis | |
6 | x | cardiovascular disease | x | LDL | x | high-density lipoprotein | level | Apheresis | |
7 | x | diabetes | x | cardiovascular disease | x | low-density lipoprotein cholesterol | x | atherosclerosis | omega-3 |
8 | x | dyslipidemia | x | cholesterol | x | high-density lipoprotein cholesterol | x | cholesterol | treatment of hypertriglyceridemia |
9 | x | high-density lipoprotein | type | x | fatty acid | x | lipoprotein | reductase inhibitor | |
10 | x | cholesterol | article | x | coronary heart disease | x | statin | Triglyceride | |
11 | x | low-density lipoprotein | x | fatty acids | x | coronary artery disease | role | adhesion molecule | |
12 | x | cardiovascular risk | x | high-density lipoprotein | clinical trial | syndrome | Evolution | ||
13 | x | fatty acids | role | x | ldl cholesterol | x | diabetes | purification process | |
14 | article | x | dyslipidemia | x | heart disease | x | trial | Prescription omega-3 | |
15 | x | insulin resistance | x | low-density lipoprotein | x | diabetes mellitus | protein | omega-6 | |
16 | type | x | cardiovascular risk | x | omega-3 fatty acid | x | risk factor | hiv-infected | |
17 | x | statin | x | hypertension | blood pressure | x | treatment | marker of inflammation | |
18 | x | hypertension | combination | x | oxidative stress | event | strong evidence | ||
19 | x | inflammation | x | insulin resistance | increased risk | therapy | attractive target | ||
20 | x | VLDL | protein | density lipoprotein | review | accelerated atherosclerosis | |||
21 | x | lipid metabolism | x | disease | x | cardiovascular risk factor | type | internalization | |
22 | combination | studies | coronary artery | mechanism | Scenario | ||||
23 | role | x | inflammation | x | statin therapy | evidence | protease inhibitor | ||
24 | x | oxidative stress | association | x | plant sterol | development | inflammatory cell | ||
25 | x | obesity | x | plasma | x | reverse cholesterol transport | use | inflammatory marker |